添加微信 添加微信
添加微信
首页: 全球医药政策

新加坡-Clinitude

时间:2021-10-21 14:00:24 来源:康安医药咨询 作者:康安医药咨询

Clinitude is the first Clinical Research Organisation to offer CRA Liaisons, providing cost-effective site monitoring for the medical device, biotechnology, and pharmaceutical industry. We are innovative, dynamic and your cost is our expertise. We are privately-owned Clinical Research Organisation with more than 12 years of experience effectively managing clinical trials. Since 2006, we have provided trial support services from start-up to completion, from Phase I-IV for pharmaceutical, biotechnology and, medical device studies in the following therapeutic areas: Immuno-Oncology, Oncology, Gastroenterology, Infectious Diseases, Rheumatology, Cardiology, Interventional Cardiology, Peripheral diseases, interventional oncology, Nephrology, Neurology, and Dermatology. Clinitude is headquartered in Belgium and we have locations in Singapore, the Philippines, and the United States. With our in-depth experience in Europe, the US and in several regions in Asia, we can handle the diversity and complexity in the local laws and regulatory submissions for each country. We are a fast-growing and energetic CRO, and we make your success our primary focus. Clinitude provides your company with a dedicated clinical team and we also offer adaptive trial management solutions. We have created a game-changing CRA Liaison service to meet the changing demands of complex clinical trials. Contact us to learn more.

Phone: 65, 6407, 11, 63 Fax: 65, 6407, 10, 01 E-mail: info@clinitude.com
Web: https://www.clinitude.com/
Add:8 Marina View, #43-01, Asia Square, Tower 1, Singapore, 018960, Republic of Singapore

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章